ACRX Acelrx Pharmaceuticals Inc

AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of therapies for the treatment of acute pain.

As of 09/30/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  02/11/2011
Outstanding shares:  147,331,963
Average volume:  1,864,220
Market cap:   $31,234,376
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -0.88
PB ratio:   -0.90
PS ratio:   35.21
Return on equity:   90.97%
Net income %:   -3,925.25%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy